Fluticasone furoate is a synthetic corticosteroid derived from fluticasone marketed by GlaxoSmithKline as Veramyst (US) and Avamys (Australia Canada EU South Africa Mexico and Israel) for the treatment of allergic rhinitis. It is marketed under the name Furamist in India by Cipla.
This page contains content from the copyrighted Wikipedia article "Fluticasone furoate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
